MCS-ICS  Medicinal Chemistry Section of the Israel Chemical Society  

17th On-Line Sympossium of The Medicinal Chemistry Section - Israel Chemical Society, June 23rd 2021

On-Line meeting:

17th Annual Meeting of MCS-ICS
Advances in Medicinal Chemistry




Date:    June 23rd 2021


                ____




FREE
REGISTRATION:
 
https://forms.gle/7Ew7qThMmxd9D6sS9

https://docs.google.com/forms/d/e/1FAIpQLSd1PwdEssRXyb421MTLHnjNOHtjbV6Pf7aznAYTUQEntLhRlg/closedform
17th On-Line Sympossium of The Medicinal Chemistry Section - Israel Chemical Society,   June 23rd 2021



Keynote Lectures:
          
     
Daniel Rauh          Sylvie Garneau-Tsodikova 
  (Technical U. at Dortmund)          (U. of Kentucky)
   

       Invited Speakers:
   
                                           
   ​           Anat Elman                           Shai Rahimipour             Amiram Goldblum             Ehud Gazit
              (Volcani Center)                                  (BIU)​                                      (HUJI)                                (TAU)​                                 
    
 
Organizing Committee:
Dr. F. Grynszpan (Ariel University)
Dr. A Raveh (
BLAVATNIK CENTER for Drug Discovery)
Executive Board: 
Prof. E. Yavin (Hebrew University of Jerusalem)
Prof. M. Fridman (Tel-Aviv University)


 

On-Line PROGRAM SCHEDULE
13:00-13:10 Opening remarks

Session 1

Chair – Liraz Chai (HUJI)
13:10-13:35 Keynote - Daniel Rauh (Technical U. at Dortmund) – Barry Cohen Awardee
  Chemical oncology - converging cancer genetics, chemical biology and medicinal chemistry
13:25-13:45 Shai Rahimipour (BIU)
  Towards Early Diagnosis of Alzheimer's Disease

Session 2

Chair - Barak Akabayov (BGU)
13:45-14:05 Amiram Goldblum (HUJI)
  Why multitargeting? Why in silico?
14:05-14:25 Ehud Gazit (TAU)
  Metabolite self-assembly as a therapeutic target
14:25-14:40 Break

Session 3

Chair – Mindy Levine (AU)
14:40-15:00 Anat Elman (Volcani Center)
  Harnessing phytochemicals to protect the brain
15:00-15:25 Keynote - Sylvie Garneau-Tsodikova (U. of Kentucky)
  Understanding and overcoming tuberculosis drug resistance

15:25-15:35

Closing remarks
 
 



WITH THE SUPPORT OF